000 01491 a2200421 4500
005 20250517101547.0
264 0 _c20171107
008 201711s 0 0 eng d
022 _a1478-6362
024 7 _a10.1186/s13075-016-1036-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avan der Velden, Daniël
245 0 0 _aMast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile.
_h[electronic resource]
260 _bArthritis research & therapy
_c06 2016
300 _a138 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aArthritis, Experimental
_ximmunology
650 0 4 _aArthritis, Rheumatoid
_ximmunology
650 0 4 _aCytokines
_xbiosynthesis
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aFlow Cytometry
650 0 4 _aInflammation
_ximmunology
650 0 4 _aMast Cells
_ximmunology
650 0 4 _aMice
650 0 4 _aMice, Inbred DBA
650 0 4 _aMice, Knockout
700 1 _aLagraauw, H Maxime
700 1 _aWezel, Anouk
700 1 _aLaunay, Pierre
700 1 _aKuiper, Johan
700 1 _aHuizinga, Tom W J
700 1 _aToes, René E M
700 1 _aBot, Ilze
700 1 _aStoop, Jeroen N
773 0 _tArthritis research & therapy
_gvol. 18
_gno. 1
_gp. 138
856 4 0 _uhttps://doi.org/10.1186/s13075-016-1036-8
_zAvailable from publisher's website
999 _c26120112
_d26120112